Excessive production of CCL18 in tumor-infiltrating macrophages was demonstrated in gastric cancer, breast cancer, colorectal cancer, and cutaneous T-cell lymphoma via CCL18 and CD68 co-immunostaining [13, 14, 16, 23]. Here, CD68 is linked to breast carcinoma.